RecruitingNCT03224312

Chongqing Primary Aldosteronism Study

Sponsor

Chongqing Medical University

Enrollment

1,500 participants

Start Date

Oct 1, 2016

Study Type

OBSERVATIONAL

Conditions

Primary Aldosteronism

Summary

We intends to conduct a series of original clinical research about PA, and establish a large cohort of PA and essential hypertension patients with long-term follow-up of cardiovascular events, renal end points etc. We will establish a large sample of blood, urine, adrenal tissue of the subjects, and the genomics,metabonomics, proteomics database, to explore the mechanism of the PA and target organ damage, risk factors, diagnostic methods and biomarkers.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria2

hypertensive patients who completed ARR screening and necessary further tests;
Voluntary to sign the informed consent.

Exclusion Criteria2

patients with severe cardiac, hepatic or renal dysfunction;
suspicious or confirmed other types of secondary hypertension, including Cushing's syndrome, pheochromocytoma and renal artery stenosis et al.

Interested in this trial?

Get notified about updates and connect with the research team.